EXPE
83
2
DRI
50
3
JBHT
52
-3
MLM
66
3
BBY
50
9
MAC
62
2
ORCL
37
3
MCK
63
-3
ESS
37
-2
ETN
65
-2
STX
66
4
FAST
46
-2
SEE
55
5
AVGO
31
5
BA
40
-2
DOV
71
2
AA
72
2
OMC
59
8
NEE
68
11
MCHP
55
5
EXPE
83
2
DRI
50
3
JBHT
52
-3
MLM
66
3
BBY
50
9
MAC
62
2
ORCL
37
3
MCK
63
-3
ESS
37
-2
ETN
65
-2
STX
66
4
FAST
46
-2
SEE
55
5
AVGO
31
5
BA
40
-2
DOV
71
2
AA
72
2
OMC
59
8
NEE
68
11
MCHP
55
5
Financhill
Back

Dorman Products, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
43

DORM
Dorman Products, Inc.

Last Price:
$124.75
Seasonality Move:
2.8%
Buy
72

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Sell
43
Dorman Products, Inc. (DORM) is a Sell

Is Dorman Products, Inc. a Buy, Sell or Hold?

  • The current Dorman Products, Inc. [DORM] share price is $126.63. The Score for DORM is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • DORM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $66.62. The Score for KYMR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DORM Stock Price Chart

What is Dorman Products, Inc.'s stock price today?

  • The Dorman Products, Inc. share price today is $126.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DORM is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $66.62
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

DORM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.04 Sell
Relative Strength Index (14 RSI): 37.89 Sell
Chaikin Money Flow: -1593 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (128.39 - 134.39) Sell
Bollinger Bands (100): (129.02 - 157.18) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.78 Buy
Relative Strength Index (14 RSI): 60.29 Buy
Chaikin Money Flow: 254539 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.36 - 66.56) Buy
Bollinger Bands (100): (43.77 - 61.91) Buy

DORM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 130.48 Sell
20-day SMA: 131.26 Sell
50-day SMA: 139.19 Sell
200-day SMA: 133.15 Sell
8-day EMA: 129.1 Sell
20-day EMA: 131.64 Sell
50-day EMA: 137.02 Sell
200-day EMA: 134.35 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.47 Buy
20-day SMA: 64.83 Buy
50-day SMA: 61.21 Buy
200-day SMA: 43.96 Buy
8-day EMA: 66.09 Buy
20-day EMA: 64.75 Buy
50-day EMA: 60.61 Buy
200-day EMA: 48.97 Buy

Dorman Products, Inc. Earnings Growth & DORM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.92 per share, and an increase next year of $0.63 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

Dorman Products, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):